Intelligent Bio Solutions INBS
NASDAQ INBS
$2.45 -0.20 (-7.36%)
As of: Aug 21, 2026 · 1:07 PM EDT

Intelligent Bio Solutions Inc. (INBS) EBT Margin (2019 - 2025)

Intelligent Bio Solutions (INBS) posted quarterly EBT Margin of 460.15% for Q1 2025, down 688.0% year-over-year from 78.26% in Q1 2024, and up 7.68% quarter-over-quarter from 498.44% in Q4 2024.

Intelligent Bio Solutions Inc. (INBS) EBT Margin (2019 - 2025) Analysis & Trends

Intelligent Bio Solutions' EBT Margin history runs 7 years deep, the most recent figure standing at 460.15% for Q1 2025.

  • In Q1 2025, EBT Margin fell 688.0% year-over-year to 460.15%; the TTM figure through Mar 2025 stood at 762.62% (up 1714.0% YoY), while the FY2023 annual figure was 1759.63%, down 83991.0% from the prior year.
  • EBT Margin for Q1 2025 stood at 460.15%, up from 498.44% in the prior quarter.
  • The five-year high for EBT Margin was 201.1% in Q2 2021, with the low at 9164.97% in Q1 2021.
  • The 5-year median for EBT Margin is 682.51% (2022), against an average of 1632.57%.
  • The sharpest annual moves came in 2022 and 2023: EBT Margin surged 846672 bps in 2022, then slumped 207808 bps in 2023.
  • Intelligent Bio Solutions' EBT Margin stood at 1948.26% in 2021, then tumbled by 48 bps to 2881.88% in 2022, then jumped by 87 bps to 364.63% in 2023, then tumbled by 37 bps to 498.44% in 2024, then rose by 8 bps to 460.15% in 2025.
  • Business Quant data shows INBS's EBT Margin at 460.15% in Q1 2025, 498.44% in Q4 2024, and 402.48% in Q3 2024.

Peer Comparison

Historic Data

Download Data
DateValue
Mar 31, 2025 -460.15%
Dec 31, 2024 -498.44%
Sep 30, 2024 -402.48%
Mar 31, 2024 -453.27%
Dec 31, 2023 -364.63%
Sep 30, 2023 -413.45%
Jun 30, 2023 -2,760.58%
Mar 31, 2023 -1,389.76%
Dec 31, 2022 -2,881.88%
Sep 30, 2022 -2,168.83%
Jun 30, 2022 -682.51%
Mar 31, 2022 -698.25%
Dec 31, 2021 -1,948.26%
Jun 30, 2021 -201.10%
Mar 31, 2021 -9,164.97%
Dec 31, 2020 -703.23%
Sep 30, 2020 -1,942.94%
Jun 30, 2020 -672.43%
Mar 31, 2020 -7,247.68%
Dec 31, 2019 -232,209.65%